データを補完しています。しばらくしてからページを更新すると最新の内容を表示できます
1405-10-3NC[C@@H]1OC(O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O.O=S(=O)(O)O1405-10-3化学的特性White or yellowish-white powder; odorless; highly hygroscopic; aqueous solution exhibits dextrorotation. High solubility in water, while almost insoluble in ethanol, ether, acetone or chloroform.
安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。
用途アミノグリコシド系抗生物質 です。細菌リボソーム 30S に結合し、タン パク質合成阻害作用を示します。グラム陽性・ 陰性菌に対して強い抗菌力を示します。
用途アミノグリコシド系抗生物質 です。細菌リボソーム 30s に結合し、タンパ ク質合成阻害作用を示します。グラム陽性・ 陰性菌に対して強い抗菌力を示します。
説明Neomycin sulfate is an aminoglycoside antibiotic and calcium channel protein inhibitor. Neomycin sulfate also binds to prokaryotic ribosomes inhibiting translation and is effective against gram-positive and gram-negative bacteria. Neomycin sulfate inhibits PLC (Phospholipase C) via binding to inositol phospholipids. It also inhibits phosphatidylcholine-PLD activity and induces Ca2+ mobilization and PLA2 activation in human platelets. Neomycin sulfate inhibits DNase I induced DNA degradation. It is used to prevent or treat skin infections caused by bacteria. It is not effective against fungal or viral infections.
使用Neomycin sulfate is an aminoglycoside antibiotic produced by S. fradiae that inhibits protein translation by binding to the small subunit of prokaryotic ribosomes. It blocks voltage-sensitive Ca2+ channels and is a potent inhibitor of skeletal muscle sarcoplasmic reticulum Ca2+ release. NEOMYCIN SULFATE has been shown to inhibit inositol phospholipid turnover, phospholipase C, and phosphatidylcholine-phospholipase D activity (IC50 = 65 μM). It is highly effective against Gram-positive and Gram-negative bacteria and is commonly used for the prevention of bacterial contamination of cell cultures.
一般的な説明Chemical structure: aminoglycoside
製造方法Neomycin sulfate is a metabolic product of Streptomyces fradiae strains, synthesized in synthetic or complex organic media with an overall glucose conversion efficiency of 19.5%[1].
現在のフィルター条件では反応記録がありません。
読み込み中…